Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC2884 K00135

Novel potent and selective inhibitor of PIM kinases

869650-21-5
DCC2885 K00518

Novel dual CLK1 and CLK3 inhibitor

DCC2886 K103 Hydrochloride

Novel inhibitor of peptidoglycan synthesis targeting the lipid II precursor

1071544-43-8
DCC2887 K-14585

Novel antagonist for proteinase-activated receptor 2 (PAR2)

880546-17-8
DCC2888 K4610422

Novel norditerpenoid inhibitor of testosterone-5α-reductase

DCC2889 K-8008

Novel inhibitor of the interaction of the N-terminally truncated RXR

2276730-51-7
DCC2890 K-8012

Novel inhibitor of the interaction of the N-terminally truncated RXR

1346513-17-4
DCC2891 Kaempulchraol P

Natural anti-inflammatory agent, inhibiting the NF-κB-mediated transactivation of a luciferase reporter gene, IL-6 production, and COX-2 expression

DCC2892 Kaempulchraol Q

Natural anti-inflammatory agent, inhibiting the NF-κB-mediated transactivation of a luciferase reporter gene, IL-6 production, and COX-2 expression

DCC2893 Kalb001

Novel mGlu4 ligand

DCC2894 Kar425

Novel antimalarial agent, providing protection to malaria-infected mice

1809050-49-4
DCC2895 Kasugamycin

Antibiotic, binding within the mRNA channel of the 30S subunit and inhibiting protein synthesis

6980-18-3
DCC2896 Kb130015

Novel activator of hERG1 potassium channels, blocking native and recombinant hERG1 channels at high voltages, but activating them at low voltages

147030-48-6
DCC2897 Kbh-a42

Novel histone deacetylase inhibitor

798543-50-7
DCC2898 Kbjk557

Novel Plk1 PBD inhibitor, showing a remarkable in vitro anticancer effect by inducing Plk1 delocalization, mitotic arrest, and apoptosis in HeLa cells

DCC2899 Kb-nb165-09

Selective inhibitor of Protein_kinase_D1>protein kinase D (PKD); Inhibitor of cell adhesion and HIV; Inhibitor of herpes simplex virus type 1 replication

172832-10-9
DCC2900 Kbp-088

Novel highly potent dual amylin and calcitonin receptor agonist (DACRA), showing long-lasting improvement of food preference and body weight loss

DCC2901 Kb-r7785

Novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the in

168158-16-5
DCC2902 Kc-11404

LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor,and 5-lipoxygenase

148490-22-6
DCC2903 Kca075

Highly specific transglutaminase 2 (TG2) inhibitor

DCC2904 Kca-1490

Dual PDE3/4 inhibitor

909719-71-7
DCC2905 Kca2 Positive Modulator 2q

Novel potent and Subtype-Selective Positive Modulator of KCa2 Channels

Page 1353 / Total 1557 FirstPrevNextLastGoto